Stem-cell transplantation for high-risk breast cancer

被引：22

作者：

Elfenbein, GJ ^{[1
]}

机构：

[1] Roger Williams Med Ctr, Providence, RI 02908 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 349卷 / 01期

关键词：

D O I：

10.1056/NEJMe030087

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：80 / 82

页数：3

共 10 条

[1] Clinical trials and survival curves: The shape of things to come [J].

Elfenbein, GJ .

ACTA HAEMATOLOGICA, 2001, 105 (03) :188-194

[2]

ELFENBEIN GJ, 2000, HEMATOPOIETIC STEM C, P100

[3] Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma:: Final analysis of the prospective LNH87-2 protocol -: A Groupe d'Etude des Lymphomes de l'Adulte Study [J].

Haioun, C ;

Lepage, E ;

Gisselbrecht, C ;

Salles, G ;

Coiffier, B ;

Brice, P ;

Bosly, A ;

Morel, P ;

Nouvel, C ;

Tilly, H ;

Lederlin, P ;

Sebban, C ;

Brière, J ;

Gaulard, P ;

Reyes, F .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :3025-3030

[4]

*IMP INF SERV, 2002, CANC INF REF FIL VER

[5] Activated T-cell and bispecific antibody immunotherapy for high-risk breast cancer - Bench to bedside [J].

Lum, LG ;

Sen, M .

ACTA HAEMATOLOGICA, 2001, 105 (03) :130-136

[6] Truth survival in clinical research: An evidence-based requiem? [J].

Poynard, T ;

Munteanu, M ;

Ratzlu, V ;

Benhamou, Y ;

Di Martino, V ;

Taieb, J ;

Opolon, P .

ANNALS OF INTERNAL MEDICINE, 2002, 136 (12) :888-895

[7] High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer [J].

Rodenhuis, S ;

Bontenbal, M ;

Beex, LVAM ;

Wagstaff, J ;

Richel, DJ ;

Nooij, MA ;

Voest, EE ;

Hupperets, P ;

van Tinteren, H ;

Peterse, HL ;

TenVergert, EM ;

de Vries, EGE .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) :7-16

[8] The Mayo Lung Cohort: A regression analysis focusing on lung cancer incidence and mortality [J].

Strauss, GM .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :1973-1983

[9] Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer [J].

Tallman, MS ;

Gray, R ;

Robert, NJ ;

LeMaistre, CF ;

Osborne, CK ;

Vaughan, WP ;

Gradishar, WJ ;

Pisansky, TM ;

Fetting, J ;

Paietta, E ;

Lazarus, HM .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) :17-26

[10] Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data [J].

Tartarone, A ;

Romano, G ;

Galasso, R ;

Iodice, G ;

D'Arena, G ;

Coccaro, M ;

Bochicchio, A ;

Sgambato, A ;

Di Renzo, N .

BONE MARROW TRANSPLANTATION, 2003, 31 (07) :525-530

← 1 →